These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Genetic Determinants and Genomic Consequences of Non-Leukemogenic Somatic Point Mutations. Weinstock JS; Chaudhry SA; Ioannou M; Viskadourou M; Reventun P; Jakubek YA; Liggett LA; Laurie C; Broome JG; Khan A; Taylor KD; Guo X; Peyser PA; Boerwinkle E; Chami N; Kenny EE; Loos RJ; Psaty BM; Russell TP; Brody JA; Yun JH; Cho MH; Vasan RS; Kardia SL; Smith JA; Raffield LM; Bidulescu A; O'Brien E; de Andrade M; Rotter JI; Rich SS; Tracy RP; Chen YI; Gu CC; Hsiung CA; Kooperberg C; Haring B; Nassir R; Mathias R; Reiner A; Sankaran V; Lowenstein CJ; Blackwell TW; Abecasis GR; Smith AV; Kang HM; Natarajan P; Jaiswal S; Bick A; Post WS; Scheet P; Auer P; Karantanos T; Battle A; Arvanitis M medRxiv; 2024 Aug; ():. PubMed ID: 39228737 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations. Jakubek YA; Reiner AP; Honigberg MC Transl Res; 2023 May; 255():171-180. PubMed ID: 36414227 [TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers are altered in UK Biobank participants with mosaic chromosomal alterations. Hubbard AK; Brown DW; Zhou W; Lin SH; Genovese G; Chanock SJ; Machiela MJ Hum Mol Genet; 2023 Nov; 32(22):3146-3152. PubMed ID: 37565819 [TBL] [Abstract][Full Text] [Related]
6. Mutation rates and fitness consequences of mosaic chromosomal alterations in blood. Watson CJ; Blundell JR Nat Genet; 2023 Oct; 55(10):1677-1685. PubMed ID: 37697102 [TBL] [Abstract][Full Text] [Related]
7. Incident disease associations with mosaic chromosomal alterations on autosomes, X and Y chromosomes: insights from a phenome-wide association study in the UK Biobank. Lin SH; Brown DW; Rose B; Day F; Lee OW; Khan SM; Hislop J; Chanock SJ; Perry JRB; Machiela MJ Cell Biosci; 2021 Jul; 11(1):143. PubMed ID: 34301302 [TBL] [Abstract][Full Text] [Related]
8. Association of Mosaic Chromosomal Alterations and Genetic Factors with the Risk of Cirrhosis. Ge X; Zhang L; Liu M; Wang X; Xu X; Yan Y; Tian C; Yang J; Ding Y; Yu C; Lu J; Jiang L; Wang Q; Zhang Q; Song C J Clin Transl Hepatol; 2024 Jun; 12(6):562-570. PubMed ID: 38974956 [TBL] [Abstract][Full Text] [Related]
9. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. Cheng C; Hong W; Li Y; Xiao X; McKay J; Han Y; Byun J; Peng B; Albanes D; Lam S; Tardon A; Chen C; Bojesen SE; Landi MT; Johansson M; Risch A; Bickeböller H; Wichmann HE; Christiani DC; Rennert G; Arnold S; Goodman G; Field JK; Davies MPA; Shete SS; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zhu M; Shen H; Zienolddiny S; Grankvist K; Johansson M; Cox A; Hong YC; Yuan JM; Lazarus P; Schabath MB; Aldrich MC; Brennan P; Li Y; Gorlova O; Gorlov I; Amos CI; J Thorac Oncol; 2023 Aug; 18(8):1003-1016. PubMed ID: 37150255 [TBL] [Abstract][Full Text] [Related]
10. Distinction of lymphoid and myeloid clonal hematopoiesis. Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986 [TBL] [Abstract][Full Text] [Related]
11. Shared and distinct genetic etiologies for different types of clonal hematopoiesis. Brown DW; Cato LD; Zhao Y; Nandakumar SK; Bao EL; Gardner EJ; Hubbard AK; DePaulis A; Rehling T; Song L; Yu K; Chanock SJ; Perry JRB; Sankaran VG; Machiela MJ Nat Commun; 2023 Sep; 14(1):5536. PubMed ID: 37684235 [TBL] [Abstract][Full Text] [Related]
12. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826 [TBL] [Abstract][Full Text] [Related]
13. Genetics of smoking and risk of clonal hematopoiesis. Levin MG; Nakao T; Zekavat SM; Koyama S; Bick AG; Niroula A; Ebert B; Damrauer SM; Natarajan P Sci Rep; 2022 May; 12(1):7248. PubMed ID: 35508625 [TBL] [Abstract][Full Text] [Related]
14. Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma. Lin SH; Khan SM; Zhou W; Brown DW; Vergara C; Wolinsky SM; Martínez-Maza O; Margolick JB; Martinson JJ; Hussain SK; Engels EA; Machiela MJ AIDS; 2023 Jul; 37(8):1307-1313. PubMed ID: 36927626 [TBL] [Abstract][Full Text] [Related]
15. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis. Weinstock JS; Gopakumar J; Burugula BB; Uddin MM; Jahn N; Belk JA; Bouzid H; Daniel B; Miao Z; Ly N; Mack TM; Luna SE; Prothro KP; Mitchell SR; Laurie CA; Broome JG; Taylor KD; Guo X; Sinner MF; von Falkenhausen AS; Kääb S; Shuldiner AR; O'Connell JR; Lewis JP; Boerwinkle E; Barnes KC; Chami N; Kenny EE; Loos RJF; Fornage M; Hou L; Lloyd-Jones DM; Redline S; Cade BE; Psaty BM; Bis JC; Brody JA; Silverman EK; Yun JH; Qiao D; Palmer ND; Freedman BI; Bowden DW; Cho MH; DeMeo DL; Vasan RS; Yanek LR; Becker LC; Kardia SLR; Peyser PA; He J; Rienstra M; Van der Harst P; Kaplan R; Heckbert SR; Smith NL; Wiggins KL; Arnett DK; Irvin MR; Tiwari H; Cutler MJ; Knight S; Muhlestein JB; Correa A; Raffield LM; Gao Y; de Andrade M; Rotter JI; Rich SS; Tracy RP; Konkle BA; Johnsen JM; Wheeler MM; Smith JG; Melander O; Nilsson PM; Custer BS; Duggirala R; Curran JE; Blangero J; McGarvey S; Williams LK; Xiao S; Yang M; Gu CC; Chen YI; Lee WJ; Marcus GM; Kane JP; Pullinger CR; Shoemaker MB; Darbar D; Roden DM; Albert C; Kooperberg C; Zhou Y; Manson JE; Desai P; Johnson AD; Mathias RA; ; Blackwell TW; Abecasis GR; Smith AV; Kang HM; Satpathy AT; Natarajan P; Kitzman JO; Whitsel EA; Reiner AP; Bick AG; Jaiswal S Nature; 2023 Apr; 616(7958):755-763. PubMed ID: 37046083 [TBL] [Abstract][Full Text] [Related]
16. Clonal hematopoiesis due to mosaic chromosomal alterations: Impact on disease risk and mortality. Hubbard AK; Brown DW; Machiela MJ Leuk Res; 2023 Mar; 126():107022. PubMed ID: 36706615 [TBL] [Abstract][Full Text] [Related]
17. Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Kishtagari A; Khan MAW; Li Y; Vlasschaert C; Marneni N; Silver AJ; von Beck K; Spaulding T; Stockton S; Snider C; Sochacki A; Dorand D; Mack TM; Ferrell PB; Xu Y; Bejan CA; Savona MR; Bick AG Blood Cancer J; 2024 Jan; 14(1):6. PubMed ID: 38225345 [TBL] [Abstract][Full Text] [Related]
18. Somatic cancer driver mutations are enriched and associated with inflammatory states in Alzheimer's disease microglia. Huang AY; Zhou Z; Talukdar M; Miller MB; Chhouk B; Enyenihi L; Rosen I; Stronge E; Zhao B; Kim D; Choi J; Khoshkhoo S; Kim J; Ganz J; Travaglini K; Gabitto M; Hodge R; Kaplan E; Lein E; De Jager PL; Bennett DA; Lee EA; Walsh CA bioRxiv; 2024 Jan; ():. PubMed ID: 38260600 [TBL] [Abstract][Full Text] [Related]
19. Association of the interaction between mosaic chromosomal alterations and polygenic risk score with the risk of lung cancer: an array-based case-control association and prospective cohort study. Qin N; Wang C; Chen C; Yang L; Liu S; Xiang J; Xie Y; Liang S; Zhou J; Xu X; Zhao X; Zhu M; Jin G; Ma H; Dai J; Hu Z; Shen H Lancet Oncol; 2022 Nov; 23(11):1465-1474. PubMed ID: 36265503 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Kar SP; Quiros PM; Gu M; Jiang T; Mitchell J; Langdon R; Iyer V; Barcena C; Vijayabaskar MS; Fabre MA; Carter P; Petrovski S; Burgess S; Vassiliou GS Nat Genet; 2022 Aug; 54(8):1155-1166. PubMed ID: 35835912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]